Central Laboratories White Papers & Articles

  1. 5 Trends To Watch This Year 3/4/2026

    Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.

  2. The Innovations Shaping 2026 CNS Clinical Trials 2/27/2026

    Explore how AI, digital tools, and site‑centered design can reduce burden, strengthen data quality, and support more reliable trial execution.

  3. Real-Time Clinical Data Insights Delivered By Automation And AI 2/26/2026

    Automated data flows and human‑guided AI enable faster, more reliable oversight into clinical trials. Learn how real‑time insights and unified monitoring support quality, efficiency, and readiness.

  4. How AI Activates The Full Potential Of Wearables In Clinical Research 2/24/2026

    Wearables provide continuous real‑world insights, and AI turns raw sensor data into meaningful evidence. With unified data infrastructure, studies gain more reliable, patient‑centered endpoints.

  5. Choosing The Right Platform: A Comparison For Regulated Industries 2/22/2026

    Regulated industries depend on tightly controlled review workflows, yet common tools rarely meet those demands. Explore how purpose‑built solutions strengthen compliance and help streamline timelines.

  6. From Standards To Study Conduct: The Operational Reality Of RBQM 2/22/2026

    Operationalizing risk-based quality management requires early identification of critical-to-quality factors, cross-functional collaboration, integrated systems, and a cultural shift toward proactive, proportionate trial oversight.

  7. How Regulatory Convergence Is Rewriting Clinical Data Management 2/22/2026

    Regulatory shifts toward structured, digital clinical trial protocols are reducing manual interpretation, enabling risk-based oversight, and supporting more efficient, transparent, end-to-end trial execution.

  8. Develop A Comprehensive Strategy For Implementing AI & Multi-Omics 2/19/2026

    Discover how a strategy-first approach to AI and multi-omics transforms complex biological data into actionable clinical decisions and more precise, targeted oncology therapies for 2026 and beyond.

  9. 5 Projections For 2026: Navigating The New Normal In Clinical Trials 2/18/2026

    In 2026, clinical trial success depends on moving from AI hype to proven utility. Unified data and seamless site experiences are no longer optional; they are the keys to trial resilience.

  10. How Platform Unification Is Shaping Clinical Trial Technology 2/18/2026

    As we look toward 2026, the conversation around clinical trial technology is shifting from simple digitization to true platform unification.